Literature DB >> 20362205

Evaluating the virulence of a Brucella melitensis hemagglutinin gene in the caprine model.

Quinesha L Perry1, Sue D Hagius, Joel V Walker, Philip H Elzer.   

Abstract

With the completion of the genomic sequence of Brucella melitensis 16M, a putative hemagglutinin gene was identified which is present in 16M and absent in Brucella abortus. The possibility of this hemagglutinin being a potential virulence factor was evaluated via gene replacement in B. melitensis yielding 16MΔE and expression in trans in B. abortus 2308-QAE. Utilizing the caprine brucellosis model, colonization and pathogenesis studies were performed to evaluate these strains. B. melitensis 16M hemagglutinin gene expression in trans in 2308-QAE revealed a significant (p≤0.05) increase in colonization and abortion rates when compared to B. abortus 2308, mimicking B. melitensis 16M virulence in pregnant goats. The B. melitensis disruption mutant's colonization and abortion rates demonstrated no attenuation in colonization but displayed a 28% reduction in abortions when compared to parental B. melitensis 16M.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20362205     DOI: 10.1016/j.vaccine.2010.03.056

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  2 in total

1.  Putative ATP-binding cassette transporter is essential for Brucella ovis pathogenesis in mice.

Authors:  Teane M A Silva; Tatiane A Paixão; Erica A Costa; Mariana N Xavier; Joicy Cortez Sá; Valéria S Moustacas; Andreas B den Hartigh; Alcina V Carvalho Neta; Sérgio C Oliveira; Renée Tsolis; Renato L Santos
Journal:  Infect Immun       Date:  2011-02-07       Impact factor: 3.441

2.  Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1.

Authors:  Jennifer L Higgins; Mercedes Gonzalez-Juarrero; Richard A Bowen
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.